PK IDIQ- Post-market Bioequivalence of Generic Drug Products
Type: Forecast
Overview
Description
PK IDIQ- Post-market Bioequivalence of Generic Drug Products
Est. Value
Min: $20,000,000
Max: $50,000,000
Max: $50,000,000
Est. Award Date
9/1/26
Source Est. Solicitation Date
7/1/26
Set Aside
To be determined
Forecast Type
New
Forecast Source
Health and Human Services
Centers for Disease Control and Prevention is forecasted to issue a new procurement for PK IDIQ- Post-market Bioequivalence of Generic Drug Products around 9/1/26 worth up to $50,000,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Centers for Disease Control and Prevention
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/19/25